Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
Jagavkar
R S
RS
Department of Radiation Oncology, Royal North-Shore Hospital, Sydney, Australia. rjagavka@doh.health.nsw.gov.au
Shakespeare
T P
TP
Stevens
M J
MJ
D018195:Adenosarcoma / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology; D004717:Endometrium / Q000473:pathology; D005260:Female; D006801:Humans; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen